Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies

Migliorini, Denis; Dietrich, Pierre-Yves; Walker, Paul Richard

doi:10.2217/imt.13.115

Scientific article

Editorial

English

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies

ContributorsMigliorini, Denis; Dietrich, Pierre-Yves; Walker, Paul Richard

Published inImmunotherapy, vol. 5, no. 11, p. 1147-1150

Publication date2013

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

MIGLIORINI, Denis, DIETRICH, Pierre-Yves, WALKER, Paul Richard. Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies. In: Immunotherapy, 2013, vol. 5, n° 11, p. 1147–1150. doi: 10.2217/imt.13.115

Article (Published version)

Identifiers

PID : unige:43346
DOI : 10.2217/imt.13.115
PMID : 24188666

Journal ISSN1750-743X

550views

0downloads

Creation12/12/2014 13:03:00

First validation12/12/2014 13:03:00

Update14/03/2023 22:26:37

Status update14/03/2023 22:26:37

Last indexation30/10/2024 21:25:44

Archive ouverte UNIGE

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies

Technical informations